Whoop's valuation has increased to $10.1 billion following the closure of a $575 million Series G funding round, nearly tripling its previous reported value of $3.6 billion. This transaction positions Whoop among the most highly valued wearable technology companies and indicates a significant shift in investor interest toward performance-focused health platforms that integrate premium hardware, continuous monitoring, and subscription-based digital services.
According to Whoop, the funding round attracted a diverse group of investors, including sovereign wealth funds, global health institutions, and prominent athletes. Collaborative Fund led the investment, with participation from Mubadala Investment Company, Qatar Investment Authority, 2PointZero Group, Abbott, Mayo Clinic, Macquarie Capital, IVP, Foundry Group, Accomplice, Affinity Partners, Glade Brook, B-Flexion, Promus Ventures, and Bullhound Capital. Notable athletes such as Cristiano Ronaldo, LeBron James, Rory McIlroy, Reggie Miller, and Niall Horan also contributed, further reinforcing Whoop’s reputation among elite performers.
The recent funding coincides with significant business milestones for Whoop. CEO Will Ahmed reported that the company concluded the previous year with a $1.1 billion bookings run rate, more than double that of the prior year. Ahmed emphasized that bookings, rather than annual recurring revenue, provide a more accurate representation of the company’s financial health. Whoop manages global hardware shipments, recurring subscription revenue, and long-term inventory cycles. This broader view helps investors understand how Whoop’s business model is different from traditional software-only companies.
Whoop’s latest funding round supports its long-term plan to offer continuous health monitoring, performance analysis, and personalized recovery insights. Whoop wearables monitor heart rate variability, sleep cycles, recovery levels, and daily strain using a sensor-rich, screenless wristband integrated with a subscription-based digital platform. The company prioritizes long-term user engagement over one-time hardware sales, thereby generating recurring revenue and increasing user commitment.
The new capital will support several priorities. Whoop plans to expand hiring across engineering, design, and data science as it pushes further into AI health insights and personalized recommendations. Marketing and global brand awareness will also grow. The company aims to accelerate international expansion and bring its fitness tracker and digital health platform to new markets where demand for health tech investment continues to rise. Whoop will keep research and development as a core focus as it evolves its biometric monitoring device for more advanced capabilities.
Abbott, the medical device giant, stands as one of the most notable additions to Whoop’s cap table. Ahmed said this partnership reflects a broader aim to deepen Whoop’s medical and clinical relevance. While details remain limited, the collaboration hints at future integrations that could bring Whoop closer to regulated health-care technology rather than staying solely in the consumer fitness category.
Investors and industry analysts have begun to question whether the company is preparing for an initial public offering (IPO). Ahmed confirmed that Whoop is developing the internal structure necessary for a public company, although no timeline was provided. At the same time, competitor Oura is reportedly considering its own public listing, further intensifying comparisons between the leading performance-tracking wearable companies.
The Whoop valuation jump also holds significance for the U.S. market. The adoption of health-tracking devices among American consumers is accelerating rapidly, while U.S. sports, wellness, and medical institutions are increasingly utilizing continuous monitoring tools. This heightened demand is reinforcing the U.S. wearable technology ecosystem and contributing to domestic job creation, manufacturing interdependencies, and the expansion of digital health services. Additionally, increased investment highlights the growing confidence in American fitness technology brands as global competition intensifies.
These trends align with the rapid expansion of the Wearable Technology Market. Companies are investing in artificial intelligence-driven analytics, sensor advancements, and innovative health data applications. Concurrently, the Digital Health Market is experiencing sustained growth as hospitals, clinics, and employers implement tools that support long-term wellness, preventive care, and remote monitoring. Industry strategies are increasingly prioritizing hybrid models that integrate consumer-grade devices with medical platforms, positioning companies such as Whoop for continued success.
Supported by robust financial resources, rising consumer demand, and a subscription model that promotes daily engagement, Whoop approaches 2026 with significant momentum. The company currently holds one of the highest valuations in the fitness wearable sector, and its most recent funding round strengthens its capacity to influence the global landscape of digital health, performance tracking, and personalized recovery technology.
